塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/02 | 6,251 | 6,251 | 6,165 | 6,193 | -10 | -0.2% | 1,199,000 |
2023/02/01 | 6,223 | 6,252 | 6,151 | 6,203 | +20 | +0.3% | 1,796,400 |
2023/01/31 | 6,420 | 6,425 | 6,177 | 6,183 | -147 | -2.3% | 3,917,500 |
2023/01/30 | 6,339 | 6,403 | 6,272 | 6,330 | -9 | -0.1% | 3,503,500 |
2023/01/27 | 6,360 | 6,369 | 6,315 | 6,339 | +25 | +0.4% | 1,186,600 |
2023/01/26 | 6,315 | 6,325 | 6,268 | 6,314 | +18 | +0.3% | 1,111,400 |
2023/01/25 | 6,280 | 6,319 | 6,261 | 6,296 | +24 | +0.4% | 1,253,400 |
2023/01/24 | 6,248 | 6,278 | 6,175 | 6,272 | +72 | +1.2% | 1,463,100 |
2023/01/23 | 6,150 | 6,214 | 6,104 | 6,200 | +92 | +1.5% | 1,633,600 |
2023/01/20 | 6,050 | 6,108 | 6,027 | 6,108 | -1 | ±0% | 1,236,300 |
2023/01/19 | 6,165 | 6,167 | 6,101 | 6,109 | -112 | -1.8% | 1,088,700 |
2023/01/18 | 6,100 | 6,227 | 6,067 | 6,221 | +159 | +2.6% | 1,611,900 |
2023/01/17 | 6,130 | 6,143 | 6,022 | 6,062 | -67 | -1.1% | 1,962,200 |
2023/01/16 | 6,151 | 6,184 | 6,106 | 6,129 | -60 | -1% | 1,213,100 |
2023/01/13 | 6,190 | 6,236 | 6,114 | 6,189 | -50 | -0.8% | 1,962,900 |
2023/01/12 | 6,300 | 6,311 | 6,211 | 6,239 | -56 | -0.9% | 1,462,900 |
2023/01/11 | 6,312 | 6,358 | 6,284 | 6,295 | -16 | -0.3% | 1,316,900 |
2023/01/10 | 6,485 | 6,486 | 6,300 | 6,311 | -127 | -2% | 1,483,600 |
2023/01/06 | 6,300 | 6,438 | 6,290 | 6,438 | +107 | +1.7% | 1,195,200 |
2023/01/05 | 6,420 | 6,430 | 6,309 | 6,331 | -72 | -1.1% | 1,396,200 |
2023/01/04 | 6,500 | 6,500 | 6,403 | 6,403 | -183 | -2.8% | 1,321,300 |
2022/12/30 | 6,597 | 6,637 | 6,563 | 6,586 | +18 | +0.3% | 1,061,400 |
2022/12/29 | 6,567 | 6,587 | 6,502 | 6,568 | -48 | -0.7% | 1,258,300 |
2022/12/28 | 6,701 | 6,717 | 6,614 | 6,616 | -121 | -1.8% | 1,390,400 |
2022/12/27 | 6,775 | 6,824 | 6,712 | 6,737 | -15 | -0.2% | 1,222,300 |
2022/12/26 | 6,724 | 6,795 | 6,681 | 6,752 | +121 | +1.8% | 1,493,800 |
2022/12/23 | 6,611 | 6,642 | 6,577 | 6,631 | -4 | -0.1% | 1,027,400 |
2022/12/22 | 6,625 | 6,645 | 6,594 | 6,635 | +35 | +0.5% | 1,055,800 |
2022/12/21 | 6,650 | 6,662 | 6,554 | 6,600 | -75 | -1.1% | 1,634,000 |
2022/12/20 | 6,777 | 6,809 | 6,637 | 6,675 | -102 | -1.5% | 2,227,500 |
2022/12/19 | 6,856 | 6,875 | 6,762 | 6,777 | -142 | -2.1% | 1,234,900 |
2022/12/16 | 6,901 | 6,944 | 6,886 | 6,919 | -76 | -1.1% | 1,320,600 |
2022/12/15 | 7,034 | 7,058 | 6,986 | 6,995 | -45 | -0.6% | 1,531,300 |
2022/12/14 | 6,984 | 7,052 | 6,956 | 7,040 | +67 | +1% | 1,989,000 |
2022/12/13 | 6,900 | 7,059 | 6,882 | 6,973 | +110 | +1.6% | 3,629,700 |
2022/12/12 | 6,751 | 6,880 | 6,750 | 6,863 | +63 | +0.9% | 1,170,700 |
2022/12/09 | 6,710 | 6,816 | 6,706 | 6,800 | +51 | +0.8% | 1,677,000 |
2022/12/08 | 6,780 | 6,794 | 6,697 | 6,749 | -51 | -0.8% | 1,432,700 |
2022/12/07 | 6,825 | 6,838 | 6,789 | 6,800 | -45 | -0.7% | 1,406,300 |
2022/12/06 | 6,841 | 6,898 | 6,841 | 6,845 | -57 | -0.8% | 1,409,600 |
2022/12/05 | 6,836 | 6,903 | 6,771 | 6,902 | +56 | +0.8% | 1,600,600 |
2022/12/02 | 6,930 | 6,930 | 6,840 | 6,846 | -103 | -1.5% | 1,710,800 |
2022/12/01 | 7,000 | 7,001 | 6,916 | 6,949 | -1 | ±0% | 2,365,100 |
2022/11/30 | 6,942 | 6,982 | 6,921 | 6,950 | -44 | -0.6% | 3,292,100 |
2022/11/29 | 6,999 | 7,051 | 6,941 | 6,994 | -21 | -0.3% | 3,201,400 |
2022/11/28 | 7,175 | 7,232 | 6,994 | 7,015 | -114 | -1.6% | 4,717,100 |
2022/11/25 | 7,135 | 7,172 | 7,050 | 7,129 | -61 | -0.8% | 4,722,800 |
2022/11/24 | 7,500 | 7,593 | 7,171 | 7,190 | +19 | +0.3% | 15,134,200 |
2022/11/22 | 7,078 | 7,261 | 7,067 | 7,171 | +193 | +2.8% | 4,271,100 |
2022/11/21 | 6,975 | 7,007 | 6,946 | 6,978 | +4 | +0.1% | 1,836,900 |
551~
600
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 235,100円 | +5.7% | +3.9% | 2.61% | 11.69倍 | 1.55倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 726,400円 | +2.2% | +10.2% | 1.65% | 13.95倍 | 1.41倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 142,000円 | +0.9% | +380.2% | 5.49% | 19.56倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 406,700円 | +1.7% | -2.9% | 3.93% | 26.68倍 | 1.40倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 211,500円 | -3.5% | -11.3% | 2.84% | 19.42倍 | 1.30倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム